āshibio
Company

Last deal

Amount

Seed

Stage

20.06.2024

Date

2

all rounds

$40M

Total amount

date founded

Financing round

General

About Company
āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

founded date

2021

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

āshibio creates treatments for rare bone and connective tissue ailments, potentially preventing symptoms or slowing their course.
Contacts
Legal Names

Legal name

AshiBio, Inc.

Financials

Funding Rounds
2
2

Number of Funding Rounds

$40M

Money Raised

Their latest funding was raised on 20.06.2024. Their latest round Seed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
20.06.2024
20.06.2024
4
$40M
MPM Capital

MPM Capital

MPM Capital invests in early-stage healthcare companies developing innovative oncology technologies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

count Of Investments

212

count Of Exists

66
Co-Investors
Investors
4
1

Number of lead investors

4

Number of investors

Investor 
Lead 
Round 
Partners 
MPM Capital

MPM Capital

MPM Capital invests in early-stage healthcare companies developing innovative oncology technologies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

count Of Investments

212

count Of Exists

66
Todd Foley

Todd Foley

Todd Foley joined MPM's Boston office in 1999 and currently manages the MPM-Novartis Strategic Funds in addition to investing MPM's main funds. Prior to MPM, Mr. Foley worked in Business Development at Genentech and management consulting with Arthur D. Little. He holds a B.S. in Chemistry from MIT and an M.B.A. from Harvard Business School.

current job

MPM Capital
MPM Capital
Mirae Asset Venture Investment

Mirae Asset Venture Investment

Mirae Asset Venture Investment is a South Korean VC founded in 1999, with a focus on investments ranging from $5-10 million.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Seongnam-si, Gyeonggi-do, South Korea

count Of Investments

230

count Of Exists

5
Agent Capital

Agent Capital

Agent Capital is a biotech venture capital firm that invests in the healthcare sector.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Financial Services, Health Care

Location

Cambridge, MA, USA

count Of Investments

37

Activity

Recent News
0